According to American Dental Association, patients using Ozempic and other GLP-1 medications report serious oral health issues, including: Increased acid exposure from reflux Reduced salivary flow (dry mouth) Nighttime clenching or grinding These factors can result in: Enamel erosion and tooth decay Gum irritation , gingivitis , and periodontal disease Severe tooth sensitivity and tooth loss The GLP-1 SuperDefender is designed as a proprietary proactive solution, offering nightly protection that safeguards against these risks before the damage becomes irreversible
Doctors select the most suitable option based on individual appetite patterns, medical considerations, response to treatment, and long-term sustainability rather than brand preference
These patches are not FDA approved, have never been tested in clinical trials, and are completely different from real GLP-1 injections
That fact has changed how regulators view RUO sales of these substances
While this study is small, we provide essential preliminary data (e.g., effect sizes) for the design and development of larger randomized control trials testing the effectiveness of GLP-1RAs on reductions in alcohol use
